CORC  > 湖南大学
Wuzhi capsule attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development
Chen, Ziqi; Liu, Fang; Zheng, Nanxin; Guo, Meng; Bao, Leilei; Zhan, Yangyang; Zhang, Mingjian; Zhao, Yuanyu; Guo, Wenyuan; Ding, Guoshan
刊名BIOMEDICINE & PHARMACOTHERAPY
2019
卷号Vol.110页码:285-293
关键词Wuzhi capsule Schisandra sphenanthera extract Non-alcoholic fatty liver disease Peroxisome proliferator-activated receptor NF-kappa B p65
ISSN号0753-3322
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4743995
专题湖南大学
作者单位1.Second Mil Med Univ, ChangZheng Hosp, Dept Organ Transplantat, Shanghai 200003, Peoples R China
2.Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China
3.Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China
推荐引用方式
GB/T 7714
Chen, Ziqi,Liu, Fang,Zheng, Nanxin,et al. Wuzhi capsule attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development[J]. BIOMEDICINE & PHARMACOTHERAPY,2019,Vol.110:285-293.
APA Chen, Ziqi.,Liu, Fang.,Zheng, Nanxin.,Guo, Meng.,Bao, Leilei.,...&Ding, Guoshan.(2019).Wuzhi capsule attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.BIOMEDICINE & PHARMACOTHERAPY,Vol.110,285-293.
MLA Chen, Ziqi,et al."Wuzhi capsule attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development".BIOMEDICINE & PHARMACOTHERAPY Vol.110(2019):285-293.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace